Table 1 Baseline characteristics in patients with poor and good collaterals
Variables | Poor collateral | Good collateral | P value |
|---|---|---|---|
(n = 311) | (n = 190) | ||
Age (years) | 62.8 ± 12.9 | 62.1 ± 12.1 | 0.547 |
Gender (Female, %) | 22.5 | 18.4 | 0.309 |
DM (%) | 42.8 | 40.5 | 0.642 |
HTN (%) | 64.3 | 65.3 | 0.848 |
Smoking (%) | 60.5 | 58.2 | 0.639 |
BMI | 24.3 ± 6.6 | 24.9 ± 5.7 | 0.277 |
eGFR (mL/min/1.73 m2) | 66.9 ± 26.9 | 68.0 ± 32.0 | 0.683 |
Laboratory data | |||
Glucose (mg/dl) | 137.7 ± 62.2 | 135.4 ± 60.4 | 0.704 |
Cholesterol (mg/dl) | 199.7 ± 45.1 | 208.3 ± 53.6 | 0.060 |
LDL-C (mg/dl) | 128.7 ± 38.3 | 136.2 ± 43.5 | 0.066 |
HDL-C (mg/dl) | 37.4 ± 9.9 | 36.0 ± 10.6 | 0.175 |
Triglyceride (mg/dl) | 168.9 ± 124.9 | 163.4 ± 146.4 | 0.660 |
Uric acid (mg/dl) | 6.54 ± 1.94 | 6.58 ± 1.81 | 0.819 |
Medication | |||
ACEI (%) | 19.1 | 20.7 | 0.725 |
ARB (%) | 15.9 | 22.3 | 0.09 |
Beta blocker (%) | 28 | 36.7 | 0.054 |